Millennium Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-461,907
Closed -$4.89M 3967
2025
Q1
$4.89M Buy
+461,907
New +$4.89M ﹤0.01% 1986
2024
Q4
Sell
-236,073
Closed -$5.48M 4056
2024
Q3
$5.48M Sell
236,073
-318,951
-57% -$7.4M ﹤0.01% 1927
2024
Q2
$13.5M Buy
555,024
+396,505
+250% +$9.65M 0.01% 1293
2024
Q1
$5.35M Buy
158,519
+24,859
+19% +$839K ﹤0.01% 1931
2023
Q4
$4.21M Buy
133,660
+56,297
+73% +$1.78M ﹤0.01% 2000
2023
Q3
$1.98M Buy
77,363
+65,599
+558% +$1.68M ﹤0.01% 2474
2023
Q2
$337K Sell
11,764
-91,647
-89% -$2.63M ﹤0.01% 3477
2023
Q1
$2.48M Buy
103,411
+62,024
+150% +$1.49M ﹤0.01% 2399
2022
Q4
$702K Buy
41,387
+22,926
+124% +$389K ﹤0.01% 3411
2022
Q3
$274K Sell
18,461
-186,135
-91% -$2.76M ﹤0.01% 4259
2022
Q2
$3.22M Buy
+204,596
New +$3.22M ﹤0.01% 2507
2021
Q4
Sell
-89,075
Closed -$4.26M 5144
2021
Q3
$4.26M Buy
+89,075
New +$4.26M ﹤0.01% 2337
2021
Q2
Sell
-105,138
Closed -$4.34M 4966
2021
Q1
$4.34M Buy
105,138
+74,273
+241% +$3.07M ﹤0.01% 2195
2020
Q4
$1.34M Buy
+30,865
New +$1.34M ﹤0.01% 2736
2020
Q3
Sell
-6,276
Closed -$293K 3580
2020
Q2
$293K Sell
6,276
-94,000
-94% -$4.39M ﹤0.01% 2969
2020
Q1
$1.36M Buy
+100,276
New +$1.36M ﹤0.01% 1833
2017
Q1
Sell
-6,221
Closed -$91K 3224
2016
Q4
$91K Sell
6,221
-4,379
-41% -$64.1K ﹤0.01% 2990
2016
Q3
$183K Buy
+10,600
New +$183K ﹤0.01% 2759
2016
Q2
Sell
-3,261
Closed -$87K 2912
2016
Q1
$87K Buy
+3,261
New +$87K ﹤0.01% 2863
2015
Q4
Sell
-3,354
Closed -$142K 3177
2015
Q3
$142K Buy
+3,354
New +$142K ﹤0.01% 3000
2015
Q1
Sell
-33,043
Closed -$863K 3039
2014
Q4
$863K Buy
33,043
+18,230
+123% +$476K ﹤0.01% 2255
2014
Q3
$1.6M Buy
14,813
+12,536
+551% +$1.35M ﹤0.01% 1757
2014
Q2
$276K Sell
2,277
-642
-22% -$77.8K ﹤0.01% 2430
2014
Q1
$371K Buy
+2,919
New +$371K ﹤0.01% 2239